NEVVI Medicare utilization intelligence

← back

BHUSHAN, VIKASM.D. NPI 1285677138 Clinician

Hematology-Oncology · DALLAS, TX

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 40 years since medical school (class of 1986, self-reported to CMS)
Location DALLAS, TX · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 77 codes billed · 94,804 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
TEXAS ONCOLOGY PA
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2008-05

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
J9025 Injection, azacitidine, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J1756 Injection, iron sucrose, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
J2405 Injection, ondansetron hydrochloride, per 1 mg
80053 Blood test, comprehensive group of blood chemicals
83735 Magnesium level
83615 Lactate dehydrogenase (enzyme) level
J2469 Injection, palonosetron hcl, 25 mcg
83521 Measurement of immunoglobulin light chains
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
Q5122 Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96375 Injection of additional new drug or substance into vein
96372 Injection of drug or substance under skin or into muscle
96413 Administration of chemotherapy into vein, 1 hour or less
J3475 Injection, magnesium sulfate, per 500 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
82787 Gammaglobulin (immune system protein) measurement, immunoglobulin subclasses
J7030 Infusion, normal saline solution , 1000 cc
96415 Administration of chemotherapy into vein, each additional hour
J3489 Injection, zoledronic acid, 1 mg
90472 Administration of vaccine, each additional vaccine
99238 Hospital discharge day management, 30 minutes or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96360 Infusion into a vein for hydration, 31-60 minutes
J1200 Injection, diphenhydramine hcl, up to 50 mg
J3490 Unclassified drugs
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
82784 Gammaglobulin (immune system protein) measurement
96417 Administration of additional new drug or substance into vein, 1 hour or less
71046 X-ray of chest, 2 views
90746 Hepatitis b vaccine, adult dosage (3 dose schedule)
96361 Infusion into a vein for hydration, each additional hour
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
85055 Reticulated (young) platelet measurement
G0009 Administration of pneumococcal vaccine
G0010 Administration of hepatitis b vaccine
G0008 Administration of influenza virus vaccine
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96523 Irrigation of implanted venous access drug delivery device
96374 Injection of drug or substance into vein
99195 Drawing of blood for a medical problem
90653 Influenza vaccine, inactivated
78816 Nuclear medicine study whole body with ct scan
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
93005 Routine electrocardiogram (ecg) using at least 12 leads with tracing
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
84443 Blood test, thyroid stimulating hormone (tsh)
85046 Red blood count automated, with additional calculations
90670 Pneumococcal vaccine, 13-valent
82232 Beta-2 microglobulin (protein) level
84550 Uric acid level, blood
81003 Automated urinalysis test
83010 Haptoglobin (serum protein) level
38241 Transplantation of patient-derived stem cells
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.